Bulgaria: Amendment to the pricing and reimbursements process for pharmaceuticals

The amendment aims at alleviating the existing regime for pricing of pharmaceuticals for home treatment of chronic, genetic and/or rare diseases and paid by the National Health Insurance Fund (NHIF). It affects the interests of individuals with health insurance and the activities of more than 290 authorisation holders, of the wholesalers of pharmaceuticals, and of pharmacies (as retailers). read more…

More from Schoenherr (Schönherr Rechtsanwälte)